Blood thinners may be safe during retina surgery, study suggests
NCT ID NCT03863548
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed French study followed 748 adults undergoing retina/vitreous surgery to see if taking blood thinners (anticoagulants or antiplatelets) raises the risk of bleeding complications. Researchers compared patients who continued or stopped their medication with those not on blood thinners. The goal is to provide clearer guidance on whether it's safe to keep taking these drugs around the time of surgery.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If the hypothesis holds, it could help doctors decide it's safe to continue blood thinners during retina/vitreous surgery, reducing patients' risk of stroke or heart attack.
- What could go wrong
- This is an observational study, not a controlled trial, so it can't prove cause and effect. Results may not apply to all surgery types or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPI-RETINAL MEMBRANE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU dijon Bourgogne
Dijon, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Built-In eye scanner could give surgeons a live 3D view during operations
- Eye surgery showdown: which technique best fixes macular holes?
- Eye fluid analysis may unlock secrets of rare eye condition
- Scientists probe eye fluids to unlock secrets of retinal detachment
- Eye surgery showdown: UNITY VCS vs CONSTELLATION trial pulled
- AI vs. human eye: study tests if smart software improves retinal reports